首页> 外文期刊>Journal of Laboratory Automation >Microfluidic Molecular Assay Platform for the Detection of miRNAs, mRNAs, Proteins, and Posttranslational Modifications at Single-Cell Resolution
【24h】

Microfluidic Molecular Assay Platform for the Detection of miRNAs, mRNAs, Proteins, and Posttranslational Modifications at Single-Cell Resolution

机译:用于在单细胞分辨率下检测miRNA,mRNA,蛋白质和翻译后修饰的微流分子分析平台

获取原文
获取外文期刊封面目录资料

摘要

Cell signaling is a dynamic and complex process. A typical signaling pathway may begin with activation of cell surface receptors, leading to activation of a kinase cascade that culminates in induction of messenger RNA (mRNA) and noncoding microRNA (miRNA) production in the nucleus, followed by modulation of mRNA expression by miRNAs in the cytosol, and end with production of proteins in response to the signaling pathway. Signaling pathways involve proteins, miRNA, and mRNAs, along with various forms of transient posttranslational modifications, and detecting each type of signaling molecule requires categorically different sample preparation methods such as Western blotting for proteins, PCR for nucleic acids, and flow cytometry for posttranslational modifications. Since we know that cells in populations behave heterogeneously,1 especially in the cases of stem cells, cancer, and hematopoiesis, there is need for a new technology that provides capability to detect and quantify multiple categories of signaling molecules in intact single cells to provide a comprehensive view of the cell’s physiological state. In this Technology Brief, we describe our automated microfluidic platform with a portfolio of customized molecular assays that can detect nucleic acids, proteins, and posttranslational modifications in single intact cells with >95% reduction in reagent requirement in under 8 h.
机译:细胞信号传导是一个动态而复杂的过程。典型的信号传导途径可能始于细胞表面受体的激活,导致激酶级联反应的激活,最终导致诱导信使RNA(mRNA)和非编码microRNA(miRNA)在细胞核中产生,然后由miRNA调节mRNA的表达。胞浆,并最终响应信号转导途径产生蛋白质。信号传导途径涉及蛋白质,miRNA和mRNA,以及各种形式的瞬时翻译后修饰,检测每种类型的信号分子需要完全不同的样品制备方法,例如蛋白质的蛋白质印迹,核酸的PCR和翻译后修饰的流式细胞仪。由于我们知道群体中的细胞行为异质,特别是在干细胞,癌症和造血细胞的情况下,因此需要一种新技术,该技术能够检测和定量完整单细胞中的多种信号分子,从而提供全面了解细胞的生理状态。在本技术简介中,我们描述了我们的自动化微流控平台,该平台具有一系列定制的分子测定法,可以检测单个完整细胞中的核酸,蛋白质和翻译后修饰,并在8小时内将试剂需求减少超过95%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号